Technology Landscape, Trends and Opportunities in the Global Orthopedic Device Market

The material technologies in orthopedic device have undergone significant change in recent years, with polyaryletherketones (PAEKs) based orthopedic implant material to metals and biologic orthopedic implants. The rising wave of new technologies such as polymers, metals and biologics are creating significant potential for advanced orthopedic devices in various medical platforms due to its improved strength and durability.

In orthopedic device market, various material technologies such as polymers, metals, ceramics, and biologics are used in the hip replacement, knee replacement, ankle replacement, and shoulder replacement applications. Increasing incidence of road accidents & sports injuries and spurring demand for minimally invasive surgical procedures are creating new opportunities for various orthopedic device technologies.

Some of the latest technological developments by various countries in the orthopedic device market are as follows:

• United States:  Johnson & Johnson received FDA approval for a new generation of knee replacement implants designed to last longer and improve patient outcomes. This signifies a significant advancement in Polymers Based technology within the US orthopedic device market.
• France:  Stryker Corporation, a major player in the orthopedic device industry, secured CE Mark approval for its additively manufactured personalized tibial tray for complex knee surgeries. This development highlights the progress of Metals Based technology, particularly in the area of 3D printing for custom-made implants.
• Germany: Zimmer Biomet, a German orthopedic device company, partnered with a leading research institute to develop next-generation biocompatible ceramics for hip and spine applications. This initiative indicates advancements in Ceramics Based technology and reflects the focus on improved biocompatibility for better patient outcomes.
• China:  Exactech, a medical device company, obtained government approval for clinical trials of its bone morphogenetic protein (BMP) product for spinal fusion procedures. This marks a step forward in Biologics Based technology, specifically in the area of bone growth stimulating agents for spinal surgeries.

This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the orthopedic device market. Some insights are depicted below by a sample figure. For more details on figures, the companies researched, and other objectives/benefits on this research report, please download the report brochure.





The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global orthopedic device technology by application, technology, and region as follows:

Technology Readiness by Material Technology

Competitive Intensity and Regulatory Compliance

Disruption Potential by Material Technology

Trends and Forecasts by Material Technology Type [$M shipment analysis from 2018 to 2030]:

• Polymers Based
• Metals Based
• Ceramics Based
• Biologics Based

Technology Trends and Forecasts by Application [$M shipment analysis from 2018 to 2030]:

• Hip Replacement
  • Polymers Based
  • Metals Based
  • Ceramics Based
  • Biologics Based
• Knee Replacement
  • Polymers Based
  • Metals Based
  • Ceramics Based
  • Biologics Based
• Ankle Replacement
  • Polymers Based
  • Metals Based
  • Ceramics Based
  • Biologics Based
• Shoulder Replacement
  • Polymers Based
  • Metals Based
  • Ceramics Based
  • Biologics Based
• Others
  • Polymers Based
  • Metals Based
  • Ceramics Based
  • Biologics Based

Technology Trends and Forecasts by Region [$M shipment analysis for 2018 to 2030]:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
  • South Korea
  • India
• The Rest of the World

Latest Developments and Innovations in the Orthopedic Device Technologies

Companies / Ecosystems

Strategic Opportunities by Material Technology

Some of the orthopedic device companies profiled in this report include Medtronic, DePuy Synthes, Stryker Corporation, NuVasive, Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, K2M Group Holdings, and RTI Surgical.

Below are the latest technological developments from top companies in the orthopedic device market:

• Stryker Corporation announced the launch of its new Triathlon® Total Ankle System, a polymer-based implant designed to improve patient outcomes in total ankle replacements. This launch caters to the growing demand for minimally invasive procedures and faster recovery times.
• Zimmer Biomet received FDA approval for its G7® Tibial Tray with Polytetrafluoroethylene (PTFE) Coating, a polymer-based innovation that aims to reduce implant loosening and improve long-term stability in total knee replacements.
• Johnson & Johnson (Depuy Synthes) announced collaboration with the American Academy of Orthopaedic Surgeons (AAOS) to develop educational programs on the benefits and proper use of metal-based implants in fracture repair surgeries. This initiative highlights the company's focus on improving patient education and surgical outcomes.
• Exactech announced a CAPEX (capital expenditure) increase of 15% earmarked for expanding their manufacturing capacity for metal-based knee and hip replacement implants. This investment reflects the anticipated growth in demand for these products.
• B. Braun Melsungen announced a strategic partnership with a leading ceramics manufacturer to develop a new generation of ceramic-on-ceramic bearings for hip replacements. This collaboration aims to improve wear resistance and longevity of these implants.
• The European Union is proposing new regulations for stricter quality control and biocompatibility testing of ceramic-based orthopedic devices. This initiative highlights the growing focus on patient safety and long-term device performance.
• Medtronic launched its next-generation INBONE® Bone Morphogenetic Protein (BMP) implant for spinal fusion surgeries. This biologics-based product boasts faster bone formation and improved fusion rates compared to previous iterations.

This report answers following 9 key questions:
Q.1 What are some of the most promising and high-growth technology opportunities for the orthopedic device market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in orthopedic device market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in orthopedic device market?
Q.6 What are the latest developments in orthopedic device technologies? Which companies are leading these developments? 
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this orthopedic device market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this orthopedic device technology space?